MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancer. Our computer vision technology integrates unique biological and spatial features of the tumor and its microenvironment, generating patient-specific tumor profiles for each patient.
This approach allows clinicians to assess tumor aggressiveness and tailor the most effective treatment strategies for individual patients.
MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancer. Our computer vision technology integrates unique biological and spatial features of the tumor and its microenvironment, generating patient-specific tumor profiles for each patient.
This approach allows clinicians to assess tumor aggressiveness and tailor the most effective treatment strategies for individual patients.
MultivisionDx launches as a spinout from the University of Helsinki following a successful Research-to-Business project
Supported by University of Helsinki and Business Finland
Research to Business funding granted for two year commercialization project